MarketPeel
Insider Trading Intelligence
Pricing
…
MG

Michael Greiner

AVNS
SVP - CHIEF FINANCIAL OFFICER · AVANOS MEDICAL, INC. · CIK 0001520392
FILING MIX · LIFETIME41%/59%
BUYS
14
SELLS
20
TOTAL VALUE
$6.49M
COMPANIES
1
ACTIVE SINCE
Jan 2020
HOLDINGS NOW
200,019
AVG SELL PX
$18.26
TRADE KIND
SHOWING 34 / 34
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
6 backtested trades · 8 horizons
Forward-return performance of every backtestable P/S trade by Michael Greiner, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d6+0.00%+2.69%+1.72%+0.96%+0.96%—
14d6+0.00%+4.90%+1.89%+3.01%+3.01%—
30d6+100.00%-2.48%-0.49%-1.99%-1.99%—
60d6+0.00%+4.74%+1.47%+3.27%+3.27%—
90d6+0.00%+6.32%+5.46%+0.87%+0.87%—
180d6+0.00%+25.98%+7.25%+18.73%+18.73%—
1y6+100.00%-23.82%+10.70%-34.51%-34.51%—
2y6+100.00%-27.87%+30.65%-58.52%-58.52%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
AVNS · 200,019 shares · as of May 13, 2025
056,066112,132168,198224,26420212022202320242025SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
FLOW · 14 buys / 20 sellsCOVERAGE · 22 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
AVNS
AVANOS MEDICAL, INC.
SALE
Former Interim CEO
19,771$12.43$245.8K204,493May 13, 2025May 14, 2025 ↗View →
AVNS
AVANOS MEDICAL, INC.
SALE
Former Interim CEO
4,474$12.43$55.6K200,019May 13, 2025May 14, 2025 ↗View →
AVNS
AVANOS MEDICAL, INC.
PURCHASEGRANT
Stock grant
73,633——73,633Mar 7, 2025Mar 11, 2025 ↗View →
AVNS
AVANOS MEDICAL, INC.
PURCHASEGRANT
Stock grant
34,316——224,264Mar 7, 2025Mar 11, 2025 ↗View →
AVNS
AVANOS MEDICAL, INC.
SALE
Interim CEO
5,112$15.30$78.2K198,433Mar 6, 2025Mar 10, 2025 ↗View →
AVNS
AVANOS MEDICAL, INC.
SALE
Interim CEO
8,485$15.30$129.8K189,948Mar 6, 2025Mar 10, 2025 ↗View →
AVNS
AVANOS MEDICAL, INC.
SALE
Interim CEO
6,048$15.13$91.5K208,187Mar 4, 2025Mar 6, 2025 ↗View →
AVNS
AVANOS MEDICAL, INC.
PURCHASE
Interim CEO
12,149——214,235Mar 4, 2025Mar 6, 2025 ↗View →
AVNS
AVANOS MEDICAL, INC.
SALE
Interim CEO
4,642$15.13$70.2K203,545Mar 4, 2025Mar 6, 2025 ↗View →
AVNS
AVANOS MEDICAL, INC.
PURCHASEGRANT
Stock grant
10,000——200,898Dec 3, 2024Dec 5, 2024 ↗View →
AVNS
AVANOS MEDICAL, INC.
PURCHASEGRANT
Stock grant
44,189——190,898Oct 29, 2024Oct 31, 2024 ↗View →
AVNS
AVANOS MEDICAL, INC.
SALE
SVP - Chief Financial Officer
1,892$19.09$36.1K153,822Mar 18, 2024Mar 19, 2024 ↗View →
AVNS
AVANOS MEDICAL, INC.
SALE
SVP - Chief Financial Officer
7,113$19.09$135.8K146,709Mar 18, 2024Mar 19, 2024 ↗View →
AVNS
AVANOS MEDICAL, INC.
PURCHASE
SVP - Chief Financial Officer
4,219——155,714Mar 18, 2024Mar 19, 2024 ↗View →
AVNS
AVANOS MEDICAL, INC.
SALE
SVP - Chief Financial Officer
714$19.12$13.7K154,981Mar 14, 2024Mar 15, 2024 ↗View →
AVNS
AVANOS MEDICAL, INC.
SALE
SVP - Chief Financial Officer
3,800$19.11$72.6K155,695Mar 14, 2024Mar 15, 2024 ↗View →
AVNS
AVANOS MEDICAL, INC.
SALE
SVP - Chief Financial Officer
110$19.16$2.1K151,495Mar 14, 2024Mar 15, 2024 ↗View →
AVNS
AVANOS MEDICAL, INC.
SALE
SVP - Chief Financial Officer
337$19.14$6.5K152,413Mar 14, 2024Mar 15, 2024 ↗View →
AVNS
AVANOS MEDICAL, INC.
SALE
SVP - Chief Financial Officer
808$19.15$15.5K151,605Mar 14, 2024Mar 15, 2024 ↗View →
AVNS
AVANOS MEDICAL, INC.
SALE
SVP - Chief Financial Officer
2,231$19.13$42.7K152,750Mar 14, 2024Mar 15, 2024 ↗View →
AVNS
AVANOS MEDICAL, INC.
PURCHASEGRANT
Stock grant
57,471$19.14$1.10M164,613Mar 6, 2024Mar 7, 2024 ↗View →
AVNS
AVANOS MEDICAL, INC.
SALE
SVP - Chief Financial Officer
5,118$19.00$97.2K159,495Mar 6, 2024Mar 7, 2024 ↗View →
AVNS
AVANOS MEDICAL, INC.
SALE
SVP - Chief Financial Officer
4,991$18.76$93.6K106,312Mar 5, 2024Mar 6, 2024 ↗View →
AVNS
AVANOS MEDICAL, INC.
SALE
SVP - Chief Financial Officer
14,710$23.97$352.6K111,303May 8, 2023May 9, 2023 ↗View →
AVNS
AVANOS MEDICAL, INC.
SALE
SVP - Chief Financial Officer
3,037$29.62$90.0K126,013Mar 6, 2023Mar 23, 2023 ↗View →
AVNS
AVANOS MEDICAL, INC.
SALE
SVP - Chief Financial Officer
3,037$29.62$90.0K127,744Mar 6, 2023Mar 7, 2023 ↗View →
AVNS
AVANOS MEDICAL, INC.
PURCHASEGRANT
Stock grant
36,350——130,781Mar 6, 2023Mar 7, 2023 ↗View →
AVNS
AVANOS MEDICAL, INC.
PURCHASEGRANT
Stock grant
34,619——129,050Mar 6, 2023Mar 23, 2023 ↗View →
AVNS
AVANOS MEDICAL, INC.
SALE
SVP - Chief Financial Officer
4,726$27.06$127.9K93,765Jan 3, 2023Jan 4, 2023 ↗View →
AVNS
AVANOS MEDICAL, INC.
PURCHASEGRANT
Stock grant
30,575——98,491Mar 4, 2022Mar 8, 2022 ↗View →
AVNS
AVANOS MEDICAL, INC.
PURCHASEGRANT
Stock grant
15,861$47.29$750.1K67,244Mar 17, 2021Mar 19, 2021 ↗View →
AVNS
AVANOS MEDICAL, INC.
PURCHASEGRANT
Stock grant
36,681$30.67$1.13M51,383May 7, 2020May 11, 2020 ↗View →
AVNS
AVANOS MEDICAL, INC.
PURCHASEGRANT
Stock grant
38,187$30.67$1.17M38,187May 7, 2020May 11, 2020 ↗View →
AVNS
AVANOS MEDICAL, INC.
PURCHASEGRANT
Stock grant
14,702$34.01$500.0K14,702Jan 2, 2020Jan 8, 2020 ↗View →
Other insiders · AVNS
Loading peer insiders…
About this filer
CIK 0001520392
ROLE
SVP - Chief Financial Officer
PRIMARY
AVNS
COMPANIES
1
ACTIVE SINCE
Jan 2020
MARKETPEEL · /INSIDER/0001520392DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback